Used primarily in the treatment of bone disorders such as Paget's disease and osteoporosis, this compound helps reduce excessive bone turnover by inhibiting osteoclast-mediated bone resorption. It is also investigated for its potential in managing bone metastases and hypercalcemia of malignancy due to its strong affinity for hydroxyapatite and ability to interfere with bone remodeling processes. Its application in rare bone diseases, including complex regional pain syndrome and fibrous dysplasia, shows promise in clinical settings.